Cargando…
Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations
BACKGROUND: Bone reconstruction in congenital craniofacial differences, which affect about 2–3% of newborns, has long been the focus of intensive research in the field of bone tissue engineering. The possibility of using mesenchymal stromal cells in regenerative medicine protocols has opened a new f...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687766/ https://www.ncbi.nlm.nih.gov/pubmed/33239080 http://dx.doi.org/10.1186/s13287-020-02017-7 |
_version_ | 1783613590647865344 |
---|---|
author | Bueno, Daniela Franco Kabayashi, Gerson Shigueru Pinheiro, Carla Cristina Gomes Tanikawa, Daniela Y. S. Raposo-Amaral, Cassio Eduardo Rocha, Diogenes Laercio Ferreira, José Ricardo Muniz Shibuya, Yoichiro Hokugo, Akishige Jarrahy, Reza ZuK, Patricia A. Passos-Bueno, Maria Rita |
author_facet | Bueno, Daniela Franco Kabayashi, Gerson Shigueru Pinheiro, Carla Cristina Gomes Tanikawa, Daniela Y. S. Raposo-Amaral, Cassio Eduardo Rocha, Diogenes Laercio Ferreira, José Ricardo Muniz Shibuya, Yoichiro Hokugo, Akishige Jarrahy, Reza ZuK, Patricia A. Passos-Bueno, Maria Rita |
author_sort | Bueno, Daniela Franco |
collection | PubMed |
description | BACKGROUND: Bone reconstruction in congenital craniofacial differences, which affect about 2–3% of newborns, has long been the focus of intensive research in the field of bone tissue engineering. The possibility of using mesenchymal stromal cells in regenerative medicine protocols has opened a new field of investigation aimed at finding optimal sources of multipotent cells that can be isolated via non-invasive procedures. In this study, we analyzed whether levator veli palatini muscle fragments, which can be readily obtained in non-invasive manner during palatoplasty in cleft palate patients, represent a novel source of MSCs with osteogenic potential. METHODS: We obtained levator veli palatini muscle fragments (3–5 mm(3)), during surgical repair of cleft palate in 5 unrelated patients. Mesenchymal stromal cells were isolated from the muscle using a pre-plating technique and other standard practices. The multipotent nature of the isolated stromal cells was demonstrated via flow cytometry analysis and by induction along osteogenic, adipogenic, and chondrogenic differentiation pathways. To demonstrate the osteogenic potential of these cells in vivo, they were used to reconstruct a critical-sized full-thickness calvarial defect model in immunocompetent rats. RESULTS: Flow cytometry analysis showed that the isolated stromal cells were positive for mesenchymal stem cell antigens (CD29, CD44, CD73, CD90, and CD105) and negative for hematopoietic (CD34 and CD45) or endothelial cell markers (CD31). The cells successfully underwent osteogenic, chondrogenic, and adipogenic cell differentiation under appropriate cell culture conditions. Calvarial defects treated with CellCeram™ scaffolds seeded with the isolated levator veli palatini muscle cells showed greater bone healing compared to defects treated with acellular scaffolds. CONCLUSION: Cells derived from levator veli palatini muscle have phenotypic characteristics similar to other mesenchymal stromal cells, both in vitro and in vivo. Our findings suggest that these cells may have clinical relevance in the surgical rehabilitation of patients with cleft palate and other craniofacial anomalies characterized by significant bone deficit. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-020-02017-7. |
format | Online Article Text |
id | pubmed-7687766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76877662020-11-30 Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations Bueno, Daniela Franco Kabayashi, Gerson Shigueru Pinheiro, Carla Cristina Gomes Tanikawa, Daniela Y. S. Raposo-Amaral, Cassio Eduardo Rocha, Diogenes Laercio Ferreira, José Ricardo Muniz Shibuya, Yoichiro Hokugo, Akishige Jarrahy, Reza ZuK, Patricia A. Passos-Bueno, Maria Rita Stem Cell Res Ther Research BACKGROUND: Bone reconstruction in congenital craniofacial differences, which affect about 2–3% of newborns, has long been the focus of intensive research in the field of bone tissue engineering. The possibility of using mesenchymal stromal cells in regenerative medicine protocols has opened a new field of investigation aimed at finding optimal sources of multipotent cells that can be isolated via non-invasive procedures. In this study, we analyzed whether levator veli palatini muscle fragments, which can be readily obtained in non-invasive manner during palatoplasty in cleft palate patients, represent a novel source of MSCs with osteogenic potential. METHODS: We obtained levator veli palatini muscle fragments (3–5 mm(3)), during surgical repair of cleft palate in 5 unrelated patients. Mesenchymal stromal cells were isolated from the muscle using a pre-plating technique and other standard practices. The multipotent nature of the isolated stromal cells was demonstrated via flow cytometry analysis and by induction along osteogenic, adipogenic, and chondrogenic differentiation pathways. To demonstrate the osteogenic potential of these cells in vivo, they were used to reconstruct a critical-sized full-thickness calvarial defect model in immunocompetent rats. RESULTS: Flow cytometry analysis showed that the isolated stromal cells were positive for mesenchymal stem cell antigens (CD29, CD44, CD73, CD90, and CD105) and negative for hematopoietic (CD34 and CD45) or endothelial cell markers (CD31). The cells successfully underwent osteogenic, chondrogenic, and adipogenic cell differentiation under appropriate cell culture conditions. Calvarial defects treated with CellCeram™ scaffolds seeded with the isolated levator veli palatini muscle cells showed greater bone healing compared to defects treated with acellular scaffolds. CONCLUSION: Cells derived from levator veli palatini muscle have phenotypic characteristics similar to other mesenchymal stromal cells, both in vitro and in vivo. Our findings suggest that these cells may have clinical relevance in the surgical rehabilitation of patients with cleft palate and other craniofacial anomalies characterized by significant bone deficit. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-020-02017-7. BioMed Central 2020-11-25 /pmc/articles/PMC7687766/ /pubmed/33239080 http://dx.doi.org/10.1186/s13287-020-02017-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Bueno, Daniela Franco Kabayashi, Gerson Shigueru Pinheiro, Carla Cristina Gomes Tanikawa, Daniela Y. S. Raposo-Amaral, Cassio Eduardo Rocha, Diogenes Laercio Ferreira, José Ricardo Muniz Shibuya, Yoichiro Hokugo, Akishige Jarrahy, Reza ZuK, Patricia A. Passos-Bueno, Maria Rita Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations |
title | Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations |
title_full | Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations |
title_fullStr | Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations |
title_full_unstemmed | Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations |
title_short | Human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations |
title_sort | human levator veli palatini muscle: a novel source of mesenchymal stromal cells for use in the rehabilitation of patients with congenital craniofacial malformations |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687766/ https://www.ncbi.nlm.nih.gov/pubmed/33239080 http://dx.doi.org/10.1186/s13287-020-02017-7 |
work_keys_str_mv | AT buenodanielafranco humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT kabayashigersonshigueru humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT pinheirocarlacristinagomes humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT tanikawadanielays humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT raposoamaralcassioeduardo humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT rochadiogeneslaercio humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT ferreirajosericardomuniz humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT shibuyayoichiro humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT hokugoakishige humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT jarrahyreza humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT zukpatriciaa humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations AT passosbuenomariarita humanlevatorvelipalatinimuscleanovelsourceofmesenchymalstromalcellsforuseintherehabilitationofpatientswithcongenitalcraniofacialmalformations |